Sameer N. Goyal

Charterhouse Square
London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 130 publications

Intranasal 6-OHDA Induces TRPM3-mediated Neuroinflammation in the pVTA: A Preclinical Early-stage Parkinson's Disease Model.

Intranasal 6-OHDA Induces TRPM3-mediated Neuroinflammation in the pVTA: A Preclinical Early-stage Parkinson's Disease Model.

Journal: Molecular neurobiology

Published: April 20, 2026

Ovarian fibrosis in polycystic ovary syndrome: Mechanisms, evidences, and clinical implications.

Ovarian fibrosis in polycystic ovary syndrome: Mechanisms, evidences, and clinical implications.

Journal: Differentiation; research in biological diversity

Published: March 28, 2026

Bromodomain protein 4 (BRD4) as a central epigenetic regulator in neuropsychiatric and neurodegenerative disorders.

Bromodomain protein 4 (BRD4) as a central epigenetic regulator in neuropsychiatric and neurodegenerative disorders.

Journal: Neuroscience

Published: March 25, 2026

Modulation of aggression by neuropeptide Y: receptor pharmacology, neural circuitry, and psychiatric relevance.

Modulation of aggression by neuropeptide Y: receptor pharmacology, neural circuitry, and psychiatric relevance.

Journal: Neuropeptides

Published: March 18, 2026

Memantine modulates TRPM3-associated glutamatergic signaling via vGLUT2 in a mouse model of obsessive-compulsive disorder.

Memantine modulates TRPM3-associated glutamatergic signaling via vGLUT2 in a mouse model of obsessive-compulsive disorder.

Journal: European journal of pharmacology

Published: February 25, 2026

CSF3R signalling beyond granulopoiesis: new paradigms in female reproductive biology.

CSF3R signalling beyond granulopoiesis: new paradigms in female reproductive biology.

Journal: Cytokine

Published: December 22, 2025

Role of GPR55 in glutamatergic and dopaminergic signaling: A review of preclinical evidence in neuropsychiatric disorders.

Role of GPR55 in glutamatergic and dopaminergic signaling: A review of preclinical evidence in neuropsychiatric disorders.

Journal: Molecular pharmacology

Published: December 11, 2025

Neuroprotective efficacy of hentriacontane against rotenone-induced apoptosis in SH-SY5Y cells: In silico and in vitro evidence of GSK3β association.

Neuroprotective efficacy of hentriacontane against rotenone-induced apoptosis in SH-SY5Y cells: In silico and in vitro evidence of GSK3β association.

Journal: Naunyn-Schmiedeberg's archives of pharmacology

Published: October 13, 2025

Interlinked Microbiota-Metabolite-Epigenome Dynamics in the Gut-Heart-Ovary Axis: New Perspectives on Cardiometabolic Risk in Polycystic Ovary Syndrome.

Interlinked Microbiota-Metabolite-Epigenome Dynamics in the Gut-Heart-Ovary Axis: New Perspectives on Cardiometabolic Risk in Polycystic Ovary Syndrome.

Journal: Current topics in medicinal chemistry

Published: September 19, 2025

Disruption of HOX Gene Regulation by Bisphenol A and Its Analogs: Epigenetic and Molecular Insights in Developmental Toxicity.

Disruption of HOX Gene Regulation by Bisphenol A and Its Analogs: Epigenetic and Molecular Insights in Developmental Toxicity.

Journal: Current pharmaceutical design

Published: September 13, 2025

Advances in Capsaicin-Based Nanocarriers: Bridging Mechanistic Insights with Therapeutic Potential and Clinical Outcomes.

Advances in Capsaicin-Based Nanocarriers: Bridging Mechanistic Insights with Therapeutic Potential and Clinical Outcomes.

Journal: Assay and drug development technologies

Published: September 02, 2025

Bempedoic Acid mitigates BCG-induced depression in mice by modulating TNF-α/NF-κB signaling and restoring brain serotonin contents.

Bempedoic Acid mitigates BCG-induced depression in mice by modulating TNF-α/NF-κB signaling and restoring brain serotonin contents.

Journal: Brain research

Published: August 12, 2025

Showing 1-12 of 130

Last Updated: 09/26/2026